Insight Molecular Diagnostics Inc. Common Stock

IMDXNASDAQ • USD
3.37 USD
↘ 0.39 (10.40%)AT CLOSE (11:59 AM EDT)
3.33
↘ 0.01 (0.30%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
3.33
↘ 0.01 (0.30%)
🟢Market: OPEN
Open?$3.71
High?$3.72
Low?$3.12
Prev. Close?$3.76
Volume?192.2K
Avg. Volume?186.8K
VWAP?$3.37
Rel. Volume?1.03x
Bid / Ask
Bid?$3.32 × 100
Ask?$3.35 × 100
Spread?$0.03
Midpoint?$3.34
Valuation & Ratios
Market Cap?121.0M
Shares Out?32.2M
Float?19.2M
Float %?67.1%
P/E Ratio?N/A
P/B Ratio?-3.84
EPS?-$1.56
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.21Adequate
Quick Ratio?1.17Adequate
Cash Ratio?0.96Adequate
Debt/Equity?-0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A▾
P/B?
-3.84CHEAP▾
P/S?
29.83HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
-3.2CHEAP▾
EV/Sales?
26.97HIGH▾
Returns & Efficiency
ROE?
159.6%STRONG▾
ROA?
-195.0%WEAK▾
Cash Flow & Enterprise
FCF?$-25369000
Enterprise Value?$109.4M
Related Companies
Loading...
News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Employees
58
Market Cap
121.0M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
www.imdxinc.com
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
MarketsMoversWatchlist